Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Imiquimod Treatment of CIN Lesions (TOPIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02329171
Recruitment Status : Terminated (Insufficient number of participants.)
First Posted : December 31, 2014
Last Update Posted : August 15, 2018
Sponsor:
Collaborator:
MEDA Pharma GmbH & Co. KG
Information provided by (Responsible Party):
Maastricht University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2016
Actual Study Completion Date : June 2016
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):